RE
Lunai Bioworks Inc.
RENB · NASDAQ
$1.42 +0.00% (+$0.00)
Valuation
-
N/A PEG N/A
P/E N/A
P/B N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
-
N/A ROA N/A
ROIC N/A
Asset turnover N/A
Debt
-
N/A Int. coverage N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Stability
82 /100
Stable Beta 0.53x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na RENB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David H. Weinstein
Employees
25
Headquarters
Los Angeles